Top Back to top

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. A Study of the EBMT Chronic Malignancies Working Party

Chronic Malignancies Working Party (CMWP)
Study number:
Short title:
Primary objective:
To develop a scoring system that will enable prediction of of early relapse within 12 months of AHSCT-1 among patients newly diagnosed with Multiple Myeloma
Key inclusion criteria:
Newly diagnosed patients with multiple myeloma having received an AHCT-1 between 2008-2018
Principal investigator:
Meral Beksac
EBMT Study coordinator:
Linda Koster
Study coordinator email: